Rezumat articol ediţie STUDIA UNIVERSITATIS BABEŞ-BOLYAI

În partea de jos este prezentat rezumatul articolului selectat. Pentru revenire la cuprinsul ediţiei din care face parte acest articol, se accesează linkul din titlu. Pentru vizualizarea tuturor articolelor din arhivă la care este autor/coautor unul din autorii de mai jos, se accesează linkul din numele autorului.

 
       
         
    STUDIA OECONOMICA - Ediţia nr.1 din 2007  
         
  Articol:   ASPECTELE STRATEGICE ALE INDUSTRIEI FARMACEUTICE LA NIVEL MONDIAL / STRATEGIC ASPECTS OF GLOBAL PHARMACEUTICAL INDUSTRY.

Autori:  ANDREJ BERTONCELJ, DRAGAN KESIČ. 		 
       
         
  Rezumat:  Globalisation process has increased competition among pharmaceutical companies and caused a fierce fight for global market share and customers’ loyalty. Nowadays, pharmaceutical industry faces new strategic challenges as a number of newly launched innovative blockbuster products is steadily decreasing despite heavy multi billion dollar investments in research and development. Intensive process of concentration is taking place in all there industry segments - originators, generic companies and specialists. Further consolidation of the industry on the global scale can be realistically forecasted as the competition for tomorrow will be predominantly among coalition of companies and stand-alone companies. Global pharmaceutical companies will cooperate and compete at the same time. Globalisation process will further spur mergers and acquisitions in the pharmaceutical industry and we will see even bigger pharmaceutical conglomerates and more oligopolisation in the future.

Keywords: global pharmaceutical industry, originators, generic pharmaceutical industry, oligopolisation, consolidation 		 
         
     
         
         
      Revenire la pagina precedentă